Autophagy inhibition of cancer stem cells promotes the efficacy of cisplatin against non-small cell lung carcinoma

BACKGROUND: Clinical treatment of non-small cell lung carcinoma (NSCLC) by cisplatin eventually results in drug resistance, which cancer stem cells and autophagy are believed to be involved in. In the present study, we aimed to explore the effect of autophagy-inhibited cancer stem cells in NSCLC. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Chengcheng, Liu, Guiping, Tian, Guangliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676261/
https://www.ncbi.nlm.nih.gov/pubmed/31368411
http://dx.doi.org/10.1177/1753466619866097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676261/
https://www.ncbi.nlm.nih.gov/pubmed/31368411
http://dx.doi.org/10.1177/1753466619866097

Ejemplares similares